A Narrative Review of the Ox40-Ox40L Pathway as a Potential Therapeutic Target in Atopic Dermatitis: Focus on Rocatinlimab and Amlitelimab
AuthID
P-017-H3B
P-017-H3B
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service